Compare BIOA & AMCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIOA | AMCX |
|---|---|---|
| Founded | 2015 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Cable & Other Pay Television Services |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 443.9M | 427.9M |
| IPO Year | 2024 | 2011 |
| Metric | BIOA | AMCX |
|---|---|---|
| Price | $23.20 | $8.39 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 3 | 5 |
| Target Price | ★ $13.50 | $6.50 |
| AVG Volume (30 Days) | ★ 661.3K | 437.7K |
| Earning Date | 11-06-2025 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $5,917,000.00 | ★ $2,316,303,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.88 | $5.41 |
| 52 Week High | $21.18 | $10.60 |
| Indicator | BIOA | AMCX |
|---|---|---|
| Relative Strength Index (RSI) | 83.98 | 32.40 |
| Support Level | $13.66 | $8.32 |
| Resistance Level | $16.43 | $9.90 |
| Average True Range (ATR) | 1.70 | 0.27 |
| MACD | 0.75 | -0.18 |
| Stochastic Oscillator | 96.51 | 4.69 |
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.
AMC Networks owns several linear pay-TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network, reached 60 million pay-TV households in the US at the end of 2024. The firm also had nearly 12.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.